CN104130192A - Imidazolyl-benzaldehyde p-phenylenediamine bis-Schiff base and preparation method thereof - Google Patents

Imidazolyl-benzaldehyde p-phenylenediamine bis-Schiff base and preparation method thereof Download PDF

Info

Publication number
CN104130192A
CN104130192A CN201410370664.7A CN201410370664A CN104130192A CN 104130192 A CN104130192 A CN 104130192A CN 201410370664 A CN201410370664 A CN 201410370664A CN 104130192 A CN104130192 A CN 104130192A
Authority
CN
China
Prior art keywords
imidazoles
phenyl aldehyde
ursol
imdazole derivatives
mol ratio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201410370664.7A
Other languages
Chinese (zh)
Other versions
CN104130192B (en
Inventor
徐婷
段洪东
卜娟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qilu University of Technology
Original Assignee
Qilu University of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qilu University of Technology filed Critical Qilu University of Technology
Priority to CN201410370664.7A priority Critical patent/CN104130192B/en
Publication of CN104130192A publication Critical patent/CN104130192A/en
Application granted granted Critical
Publication of CN104130192B publication Critical patent/CN104130192B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/61Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91Nitro radicals
    • C07D233/92Nitro radicals attached in position 4 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91Nitro radicals
    • C07D233/92Nitro radicals attached in position 4 or 5
    • C07D233/93Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by halogen atoms, attached to other ring members
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1044Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Materials Engineering (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention relates to an imidazolyl-benzaldehyde p-phenylenediamine bis-Schiff base and a preparation method thereof. The preparation method comprises: firstly taking imidazol and derivatives and p-fluorobenzaldehyde as raw materials to prepare 4-imidazolyl benzaldehyde or imidazol-derivative benzaldehyde; and then taking the product and p-phenylenediamine as raw materials to obtain a series of bis-Schiff bases with a conjugated structure and a rigid plane through a condensation reaction of an aldehyde group and a primary amine. The technological synthesis is low in cost, high in yield, easily controllable in reaction conditions and simple in product purification. The new compounds have extremely good fluorescent performance, also have selectivity on metal ions, and are applicable to material field or sensor field.

Description

Two Schiff's base of a kind of imidazoles phenyl aldehyde contracting Ursol D and preparation method thereof
Technical field
The present invention relates to two Schiff's base of a kind of imidazoles phenyl aldehyde contracting Ursol D and preparation method thereof, this compound has rigid planar structure, show good fluorescence property, there is the C=N functional group containing lone-pair electron simultaneously, there is very strong coordination ability with metal ion, there is good ion selectivity.
Background technology
Imidazoles is a kind of five member ring heterocyclic compound that contains two nitrogen-atoms, as a kind of important heterogeneous ring compound, is extensively present in natural product.Imidazoles has very high biological activity, can be widely used in the aspects such as medicine, agricultural chemicals, dyestuff and photographic developer.In addition, glyoxaline compound, as organic nitrogen-containing heterogeneous ring compound, also has good coordination ability, occupies very important status in coordination chemistry.
Because imidazole molecule has a closed large π key, and the not sp of Cheng Jian of one of them nitrogen-atoms 2on track, have a pair of lone-pair electron, therefore it has aromaticity, and both aobvious slightly acidic, can show again weakly alkaline.This has just determined the diversity of imidazoles generation chemical reaction (particularly substitution reaction), generate the diversity of derivative, also determined that glyoxaline compound has such as ligand complex, the premium propertiess such as the transitivity of electronics, proton, have more determined that this compounds is with a wide range of applications.Glyoxaline compound has conjugate acid and base performance and complex coordination performance, enjoys the good reputation of " biological catalyst " " bio-ligand ".
Schiff base compounds, as a kind of important industrial chemicals, is applied very extensive.Have the physical material performances such as good optical, electrical, magnetic due to Schiff's base, the physiologically actives such as good ligancy and unique antibacterial, anticancer, weeding, make it be subject to extensive concern.At present carry out a lot of reports about imidazolium compounds in medicine, agricultural chemicals, field of fine chemical, but at present two the synthetic of Schiff's base of imidazoles have not been reported.
Summary of the invention
The object of the invention is for the deficiencies in the prior art, provide the imidazoles phenyl aldehyde contracting Ursol D that a class is new two Schiff's base, this Schiff's base has good fluorescence property and ion selectivity energy, and this technique have easy to operate, cost is low, condition is easily controlled, productive rate advantages of higher.
Another object of the present invention is to provide the preparation method of the two Schiff's base of described imidazoles phenyl aldehyde contracting Ursol D.
Another object of the present invention is to provide the application of the two Schiff's base of described imidazoles phenyl aldehyde contracting Ursol D.
In order to realize such object, technical scheme of the present invention is as follows:
The two Schiff's base of a kind of imidazoles phenyl aldehyde contracting Ursol D, its structural formula is as follows:
R 1for methoxyl group, hydrogen, R 2for hydrogen, fluorine, chlorine, R 3for hydrogen, carboxyl, nitro, hydroxyl, cyano group.
Preferred R 1for methoxyl group, R 2for chlorine, R 3for nitro;
Wherein methoxyl group is outstanding electron-donating group, and chlorine atom has very strong electronegativity, and nitro has good electron attraction;
This compound is mainly used in Material Field or sensor field;
A preparation method for the two Schiff's base of imidazoles phenyl aldehyde contracting Ursol D, its preparation method is as follows:
1) take imidazoles or imdazole derivatives and p-Fluorobenzenecarboxaldehyde and be dissolved in solvent;
The mol ratio of described imidazoles or imdazole derivatives and p-Fluorobenzenecarboxaldehyde is 1:1~3:1; The mol ratio of described imidazoles or imdazole derivatives and solvent is 1:15~1:90; Described imdazole derivatives is 5-nitroimidazole, 2-methoxyl group imidazoles, the chloro-5-nitroimidazole of 4-; Described solvent is DMF, dimethyl sulfoxide (DMSO), ethanol;
The mol ratio of preferred imidazoles or imdazole derivatives and p-Fluorobenzenecarboxaldehyde is 1.5:1;
2) take salt of wormwood and join step 1) described solution, the mol ratio of imidazoles or imdazole derivatives and salt of wormwood is 1:1~1:4, at 50~120 DEG C, constant temperature stirs 10~20h, be cooled to after room temperature, pour in 100mL frozen water, have yellow solid to separate out, suction filtration, with ethyl alcohol recrystallization, obtain sterling, vacuum-drying obtain 4-imidazolyl benzaldehyde or imdazole derivatives phenyl aldehyde;
3) taking step 2) 4-imidazolyl benzaldehyde or imdazole derivatives phenyl aldehyde and Ursol D be dissolved in solvent;
Described 4-imidazolyl benzaldehyde or the mol ratio of imdazole derivatives phenyl aldehyde and Ursol D are 2:1~5:1;
The mol ratio of preferred 4-imidazolyl benzaldehyde or imdazole derivatives and Ursol D is 2:1;
Described 4-imidazolyl benzaldehyde or the mol ratio of imdazole derivatives phenyl aldehyde and solvent are 1:5~1:90;
Described solvent is DMF, dimethyl sulfoxide (DMSO), ethanol;
4) take hydrochloric acid and join step 3) in described mixing solutions, the mol ratio of 4-imidazolyl benzaldehyde or imdazole derivatives phenyl aldehyde and hydrochloric acid is 1:1~1:5, isothermal reaction 1~12h at 25~90 DEG C, underpressure distillation is except desolventizing, obtain yellow powder shape solid, purify by ethanol, methyl alcohol or re-crystallizing in ethyl acetate, vacuum-drying obtain the finished product;
Described recrystallization solvent used is ethanol, methyl alcohol or ethyl acetate.
The present invention reacts imidazole and its derivants with p-Fluorobenzenecarboxaldehyde, be prepared into 4-imidazolyl benzaldehyde or imdazole derivatives phenyl aldehyde, it is reacted to obtain to the two Schiff's base of a series of imidazoles phenyl aldehyde contracting Ursol D based on imidazoles with Ursol D, after tested, this compound has good fluorescence property and ion selectivity (the results are shown in accompanying drawing 5-10).
New compound of the present invention can be used as probe application in ion detection field, also can be used as fluorescent material for Material Field.
Brief description of the drawings:
(1) Fig. 1,2,3,4 is respectively the hydrogen nuclear magnetic resonance spectrogram of compound 1,2,3 and 4.
(2) Fig. 5,6 is respectively uv absorption spectra and the fluorescence spectrum figure of compound.
(3) Fig. 7,8,9,10 is respectively the fluorogram of compound to metalloform-selective.
Embodiment:
Technical scheme for a better understanding of the present invention, below is described in further detail by specific embodiment.
Embodiment 1
Take imidazoles 0.680g (10mmol), take p-Fluorobenzenecarboxaldehyde 1.240g (10mmol) and Anhydrous potassium carbonate 1.380g (10mmol), be dissolved in the N of 25mL, in dinethylformamide, join in the four-hole boiling flask of the 50mL that thermometer, whipping appts are housed.Isothermal reaction 20h at 60 DEG C, is cooled to after room temperature, pours in 100mL frozen water, has yellow solid to separate out, suction filtration, and with ethyl alcohol recrystallization, vacuum-drying 8h at 50 DEG C, obtains 4-imidazolyl benzaldehyde.
Take 4-imidazolyl benzaldehyde 0.172g (1mmol), take Ursol D 0.054g (0.500mmol), be dissolved in the DMF of 5mL, join in the single port flask of the 10mL that thermometer, whipping appts are housed.Then in above-mentioned mixed solution, add hydrochloric acid 0.073g (2mmol), constant temperature stirring reaction 12h at 25 DEG C, underpressure distillation is except desolventizing, obtain yellow powder shape solid, with ethyl alcohol recrystallization, 50 DEG C of vacuum-drying 6h, obtain final purpose product: compound 1 (the two Schiff's base of imidazoles phenyl aldehyde contracting Ursol D).Productive rate: 90%.
Ultimate analysis: C 26h 20n 6: %C:75.89 (75.00); %H:4.83 (4.81); %N:19.28 (20.19) (being observed value in bracket).
Compound 1 nmr analysis (nuclear magnetic spectrogram is shown in accompanying drawing 1):
Must table 1 by the structural formula to compound 1 and hydrogen nuclear magnetic resonance spectrum analysis.This compound has 10 kinds of hydrogen, and near the fignal center wherein occurring 7.96-7.76ppm is proton 1,2,10 fignal center, and its peak area is 3.09; The fignal center occurring at 8.75ppm annex is the fignal center of proton 3, and its peak area is 1.00; Near the fignal center occurring 7.40ppm is the fignal center of proton 4,6, and its peak area is 2.00; The fignal center occurring at 8.08ppm annex is the fignal center of proton 5,7, and its peak area is 2.04; Near the fignal center occurring 8.41ppm is the fignal center of proton 8, and its peak area is 0.99; Near the fignal center occurring 7.16ppm is the fignal center of proton 9, and its peak area is 1.01.This shows, the hydrogen nuclear magnetic resonance spectrogram of compound 1 has well met the structure of compound 1, i.e. the two Schiff's base of imidazoles phenyl aldehyde contracting Ursol D.
Table 1 compound 1 1the chemical shiftsum peak ownership of HNMR
S: unimodal; D: doublet; M: multiplet
Embodiment 2
Take 5-nitroimidazole 2.260g (20mmol), take p-Fluorobenzenecarboxaldehyde 1.860g (15mmol) and Anhydrous potassium carbonate 2.760g (20mmol), be dissolved in the N of 30mL, in dinethylformamide, join in the four-hole boiling flask of the 50mL that thermometer, whipping appts are housed.Isothermal reaction 16h at 80 DEG C, is cooled to after room temperature, pours in 100mL frozen water, has yellow solid to separate out, suction filtration, and with ethyl alcohol recrystallization, vacuum-drying 10h at 50 DEG C, obtains 4-(5-nitro-1-imidazolyl) phenyl aldehyde.
Take 4-(5-nitro-1-imidazolyl) phenyl aldehyde 0.217g (1mmol), take Ursol D 0.027g (0.250mmol), be dissolved in the DMF of 4mL, join in the single port flask of the 10mL that thermometer, whipping appts are housed.Then in above-mentioned mixed solution, add hydrochloric acid 0.107g (2.932mmol), constant temperature stirring reaction 10h at 50 DEG C, underpressure distillation is except desolventizing, obtain yellow powder shape solid, with ethyl alcohol recrystallization, 60 DEG C of vacuum-drying 6h obtain final purpose product: compound 2 (the two Schiff's base of 5-nitroimidazole phenyl aldehyde contracting Ursol D).Productive rate: 82%.
Ultimate analysis: C 26h 18n 8o 4: %C:62.08 (61.66); %H:3.57 (3.49); %N:21.68 (22.13); %O:12.67 (12.65) (being observed value in bracket).
Compound 2 nmr analysis (nuclear magnetic spectrogram is shown in accompanying drawing 2):
Must table 2 by the structural formula to compound 2 and hydrogen nuclear magnetic resonance spectrum analysis.This compound has 9 kinds of hydrogen, and near the fignal center wherein occurring 7.75ppm is the fignal center of proton 1,2, and its peak area is 2.00; The fignal center occurring at 8.88ppm annex is the fignal center of proton 3, and its peak area is 1.00; Near the fignal center occurring 7.40ppm is the fignal center of proton 4,6, and its peak area is 2.04; The fignal center occurring at 8.08ppm annex is the fignal center of proton 5,7, and its peak area is 2.00; Near the fignal center occurring 8.41ppm is the fignal center of proton 8, and its peak area is 1.01; Near the fignal center occurring 7.21ppm is the fignal center of proton 9, and its peak area is 1.01.This shows, the hydrogen nuclear magnetic resonance spectrogram of compound 2 has well met the structure of compound 2, i.e. the two Schiff's base of 5-nitroimidazole phenyl aldehyde contracting Ursol D.
Table 2 compound 2 1the chemical shiftsum peak ownership of HNMR
S: unimodal; D: doublet; M: multiplet
Embodiment 3
Take 2-methoxyl group imidazoles 2.940g (30mmol), take p-Fluorobenzenecarboxaldehyde 1.860g (15mmol) and Anhydrous potassium carbonate 4.140g (30mmol), be dissolved in the N of 40mL, in dinethylformamide, join in the four-hole boiling flask of the 100mL that thermometer, whipping appts are housed.Isothermal reaction 14h at 90 DEG C, is cooled to after room temperature, pours in 100mL frozen water, has yellow solid to separate out, suction filtration, and with ethyl alcohol recrystallization, vacuum-drying 8h at 60 DEG C, obtains 4-(2-methoxyl group-1-imidazolyl) phenyl aldehyde.
Take 4-(2-methoxyl group-1-imidazolyl) phenyl aldehyde 0.606 (3mmol), take Ursol D 0.130g (1.250mmol), be dissolved in the DMF of 4mL, join in the single port flask of the 10mL that thermometer, whipping appts are housed.Then in above-mentioned mixed solution, add hydrochloric acid 0.178g (4.877mmol), constant temperature stirring reaction 6h at 60 DEG C, underpressure distillation is except desolventizing, obtain yellow powder shape solid, with ethyl alcohol recrystallization, 50 DEG C of vacuum-drying 6h obtain final purpose product: compound 3 (the two Schiff's base of 2-methoxyl group imidazoles phenyl aldehyde contracting Ursol D).Productive rate: 84%.
Ultimate analysis: C 28h 26n 6o 2: %C:71.08 (70.29); %H:4.93 (5.44); %N:18.28 (17.57); %O:5.71 (6.69) (being observed value in bracket).
Compound 3 nmr analysis (nuclear magnetic spectrogram is shown in accompanying drawing 3):
Must table 3 by the structural formula to compound 3 and hydrogen nuclear magnetic resonance spectrum analysis.This compound has 10 kinds of hydrogen, and near the fignal center wherein occurring 6.65ppm is the fignal center of proton 1,2, and its peak area is 1.99; The fignal center occurring at 8.14ppm annex is the fignal center of proton 3, and its peak area is 1.00; Near the fignal center occurring 7.43-7.48ppm is proton 4,6,9 fignal center, and its peak area is 3.01; The fignal center occurring at 8.01ppm annex is the fignal center of proton 5,7, and its peak area is 2.00; Near the fignal center occurring 7.27ppm is the fignal center of proton 8, and its peak area is 1.00; Near the fignal center occurring 3.85ppm is the fignal center of proton 10, and its peak area is 2.99.This shows, the hydrogen nuclear magnetic resonance spectrogram of compound 3 has well met the structure of compound 3, i.e. the two Schiff's base of 2-methoxyl group imidazoles phenyl aldehyde contracting Ursol D.
Table 3 compound 3 1the chemical shiftsum peak ownership of HNMR
S: unimodal; D: doublet; M: multiplet
Embodiment 4
Take the chloro-5-nitroimidazole of 4-2.970g (20mmol), take p-Fluorobenzenecarboxaldehyde 0.992g (8mmol) and Anhydrous potassium carbonate 9.960g (70mmol), be dissolved in the N of 35mL, in dinethylformamide, join in the four-hole boiling flask of the 100mL that thermometer, whipping appts are housed.Isothermal reaction 12h at 100 DEG C, is cooled to after room temperature, pours in 100mL frozen water, has yellow solid to separate out, suction filtration, and with ethyl alcohol recrystallization, vacuum-drying 8h at 50 DEG C, obtains 4-(the chloro-5-nitro-1-of 4-imidazolyl) phenyl aldehyde.
Take 4-(the chloro-5-nitro-1-of 4-imidazolyl) phenyl aldehyde 0.758g (3mmol), take Ursol D 0.161g (1.505mmol), be dissolved in the DMF of 5mL, join in the single port flask of the 10mL that thermometer, whipping appts are housed.Then in above-mentioned mixed solution, add hydrochloric acid 0.365g (10mmol), constant temperature stirring reaction 5h at 70 DEG C, underpressure distillation is except desolventizing, obtain yellow powder shape solid, with ethyl alcohol recrystallization, 50 DEG C of vacuum-drying 6h obtain final purpose product: compound 4 (the two Schiff's base of the chloro-5-nitroimidazole of 4-phenyl aldehyde contracting Ursol D).Productive rate: 88%.
Ultimate analysis: C 26h 16n 8o 4cl 2: %C:53.08 (54.07); %H:2.57 (2.78); %N:20.68 (19.41); %O:10.67 (11.09); %Cl:13.00 (12.65) (being observed value in bracket).
Compound 4 nmr analysis (nuclear magnetic spectrogram is shown in accompanying drawing 4):
Must table 4 by the structural formula to compound 4 and hydrogen nuclear magnetic resonance spectrum analysis.This compound has 8 kinds of hydrogen, and near the fignal center wherein occurring 7.42ppm is the fignal center of proton 1,2, and its peak area is 2.04; The fignal center occurring at 9.01ppm annex is the fignal center of proton 3, and its peak area is 0.99; Near the fignal center occurring 8.05ppm is the fignal center of proton 4,6, and its peak area is 1.99; The fignal center occurring at 7.68ppm annex is the fignal center of proton 5,7, and its peak area is 1.99; Near the fignal center occurring 8.56ppm is the fignal center of proton 8, and its peak area is 1.00.This shows, the hydrogen nuclear magnetic resonance spectrogram of compound 4 has well met the structure of compound 4, i.e. the two Schiff's base of the chloro-5-nitroimidazole of 4-phenyl aldehyde contracting Ursol D.
Table 4 compound 4 1the chemical shiftsum peak ownership of HNMR
S: unimodal; D: doublet; M: multiplet
Experimental example
1, compound fluorescence property test
The compound 1,2,3,4 of the purification process of learning from else's experience, utilizes DMF to dissolve, dilute, and is configured to 1.0 × 10 -5the sample solution of mol/L.Utilize the uv absorption spectra (the results are shown in accompanying drawing 5) of ultraviolet-visible pectrophotometer working sample, according to the uv-absorption maximum wavelength of the compound recording, utilize the fluorescence exciting wavelength of F-4600 fluorescent spectrophotometer assay compound, and measure the fluorescence spectrum (the results are shown in accompanying drawing 6) of compound.
2, utilize DMF to make solvent and prepare respectively 1.0 × 10 -5the compound 1,2,3,4 of mol/L and the 1:1 mixing solutions of metal ion.The fluorescence spectrum (the results are shown in accompanying drawing 7,8,9,10) of test compounds and metal ion solution.
Result of study shows: compound has fluorescence property, and compound 1 has good selectivity to cupric ion (II) simultaneously; Compound 2 has good selectivity for cadmium ion (II); Compound 3 has good selectivity for zine ion (II); Compound 4 (II) has good selectivity for cadmium ion.

Claims (6)

1. the two Schiff's base of imidazoles phenyl aldehyde contracting Ursol D, is characterized in that: its structural formula is as follows:
R 1for methoxyl group, hydrogen, R 2for hydrogen, fluorine, chlorine, R 3for hydrogen, carboxyl, nitro, hydroxyl, cyano group.
2. the application of compound as claimed in claim 1, is characterized in that: be applied to Material Field or sensor field.
3. the preparation method of the two Schiff's base of a kind of imidazoles phenyl aldehyde contracting Ursol D as claimed in claim 1, is characterized in that: its preparation method is as follows:
1) take imidazoles or imdazole derivatives and p-Fluorobenzenecarboxaldehyde and be dissolved in solvent;
The mol ratio of described imidazoles or imdazole derivatives and p-Fluorobenzenecarboxaldehyde is 1:1~3:1; The mol ratio of described imidazoles or imdazole derivatives and solvent is 1:15~1:90; Described imdazole derivatives is 5-nitroimidazole, 2-methoxyl group imidazoles, the chloro-5-nitroimidazole of 4-; Described solvent is DMF, dimethyl sulfoxide (DMSO), ethanol;
2) take salt of wormwood and join step 1) described solution, the mol ratio of imidazoles or imdazole derivatives and salt of wormwood is 1:1~1:4, at 50~120 DEG C, constant temperature stirs 10~20h, be cooled to after room temperature, pour in 100mL frozen water, have yellow solid to separate out, suction filtration, with ethyl alcohol recrystallization, obtain sterling, vacuum-drying obtain 4-imidazolyl benzaldehyde or imdazole derivatives phenyl aldehyde;
3) taking step 2) 4-imidazolyl benzaldehyde or imdazole derivatives phenyl aldehyde and Ursol D be dissolved in solvent;
Described 4-imidazolyl benzaldehyde or the mol ratio of imdazole derivatives phenyl aldehyde and Ursol D are 2:1~5:1;
Described 4-imidazolyl benzaldehyde or the mol ratio of imdazole derivatives phenyl aldehyde and solvent are 1:5~1:90;
Described solvent is DMF, dimethyl sulfoxide (DMSO), ethanol;
4) take hydrochloric acid and join step 3) in described mixing solutions, the mol ratio of 4-imidazolyl benzaldehyde or imdazole derivatives phenyl aldehyde and hydrochloric acid is 1:1~1:5, isothermal reaction 1~12h at 25~90 DEG C, underpressure distillation is except desolventizing, obtain yellow powder shape solid, purify by ethanol, methyl alcohol or re-crystallizing in ethyl acetate, vacuum-drying obtain the finished product.
4. the two Schiff's base of a kind of imidazoles phenyl aldehyde contracting Ursol D as claimed in claim 1, is characterized in that R in its structural formula 1for methoxyl group, R 2for chlorine, R 3for nitro.
5. the preparation method of the two Schiff's base of a kind of imidazoles phenyl aldehyde contracting Ursol D as claimed in claim 3, is characterized in that, the mol ratio of described imidazoles or imdazole derivatives and p-Fluorobenzenecarboxaldehyde is 1.5:1.
6. the preparation method of the two Schiff's base of a kind of imidazoles phenyl aldehyde contracting Ursol D as claimed in claim 3, is characterized in that, described 4-imidazolyl benzaldehyde or the mol ratio of imdazole derivatives and Ursol D are 2:1.
CN201410370664.7A 2014-07-30 2014-07-30 Imidazolyl-benzaldehyde p-phenylenediamine bis-Schiff base and preparation method thereof Expired - Fee Related CN104130192B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410370664.7A CN104130192B (en) 2014-07-30 2014-07-30 Imidazolyl-benzaldehyde p-phenylenediamine bis-Schiff base and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410370664.7A CN104130192B (en) 2014-07-30 2014-07-30 Imidazolyl-benzaldehyde p-phenylenediamine bis-Schiff base and preparation method thereof

Publications (2)

Publication Number Publication Date
CN104130192A true CN104130192A (en) 2014-11-05
CN104130192B CN104130192B (en) 2017-05-24

Family

ID=51803088

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410370664.7A Expired - Fee Related CN104130192B (en) 2014-07-30 2014-07-30 Imidazolyl-benzaldehyde p-phenylenediamine bis-Schiff base and preparation method thereof

Country Status (1)

Country Link
CN (1) CN104130192B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105384701A (en) * 2015-11-26 2016-03-09 齐鲁工业大学 Benzotriazole benzaldehyde condensate ursol bis-Schiff base and preparation method thereof
CN106966981A (en) * 2017-04-25 2017-07-21 陈宗源 A kind of combined reactor and the method that pyrazolyl benzaldehyde-p-phenylenediamine bi-schiff base is prepared using the combined reactor
CN107314991A (en) * 2017-05-16 2017-11-03 西北农林科技大学 Schiff base compound as cyanide ion and copper ion fluorescence probe application
CN112390805A (en) * 2020-11-27 2021-02-23 齐鲁工业大学 Benzimidazole benzaldehyde fluorescein hydrazide Schiff base and preparation method thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3306196A1 (en) * 1983-02-23 1984-08-23 A. Nattermann & Cie GmbH, 5000 Köln Process for the preparation of imidazolylbenzaldehydes
WO2006072002A2 (en) * 2004-12-30 2006-07-06 E.I. Dupont De Nemours And Company Organometallic complexes
CN102584670A (en) * 2012-01-15 2012-07-18 山东轻工业学院 Indole-3-formaldehyde shrinkage phenylenediamine bis-schiff base and preparation method thereof
CN102898353A (en) * 2012-11-08 2013-01-30 山东轻工业学院 Carbazole benzaldehyde o-phenylenediamine bis-schiff base and preparation method thereof
CN102911111A (en) * 2012-11-08 2013-02-06 山东轻工业学院 Carbazole benzaldehyde-p-phenylenediamine bi-schiff base and preparation method thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3306196A1 (en) * 1983-02-23 1984-08-23 A. Nattermann & Cie GmbH, 5000 Köln Process for the preparation of imidazolylbenzaldehydes
WO2006072002A2 (en) * 2004-12-30 2006-07-06 E.I. Dupont De Nemours And Company Organometallic complexes
CN102584670A (en) * 2012-01-15 2012-07-18 山东轻工业学院 Indole-3-formaldehyde shrinkage phenylenediamine bis-schiff base and preparation method thereof
CN102898353A (en) * 2012-11-08 2013-01-30 山东轻工业学院 Carbazole benzaldehyde o-phenylenediamine bis-schiff base and preparation method thereof
CN102911111A (en) * 2012-11-08 2013-02-06 山东轻工业学院 Carbazole benzaldehyde-p-phenylenediamine bi-schiff base and preparation method thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
VIJAY K. MARRAPU等: "Novel aryloxy azolyl chalcones with potent activity against Mycobacterium tuberculosis H37Rv", 《EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY》 *
相海鹰: "对-N 咪唑基苯甲醛的合成、表征及量化计算研究", 《化工矿物与加工》 *
韩巧荣,等: "N-乙基咔唑席夫碱EDA-NECD的合成及其对Cu2+的识别研究", 《功能材料》 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105384701A (en) * 2015-11-26 2016-03-09 齐鲁工业大学 Benzotriazole benzaldehyde condensate ursol bis-Schiff base and preparation method thereof
CN106966981A (en) * 2017-04-25 2017-07-21 陈宗源 A kind of combined reactor and the method that pyrazolyl benzaldehyde-p-phenylenediamine bi-schiff base is prepared using the combined reactor
CN106966981B (en) * 2017-04-25 2020-08-18 陈宗源 Combined reactor and method for preparing pyrazolyl benzaldehyde p-phenylenediamine bis-Schiff base by using same
CN107314991A (en) * 2017-05-16 2017-11-03 西北农林科技大学 Schiff base compound as cyanide ion and copper ion fluorescence probe application
CN112390805A (en) * 2020-11-27 2021-02-23 齐鲁工业大学 Benzimidazole benzaldehyde fluorescein hydrazide Schiff base and preparation method thereof

Also Published As

Publication number Publication date
CN104130192B (en) 2017-05-24

Similar Documents

Publication Publication Date Title
Xu et al. A carbazole-functionalized metal–organic framework for efficient detection of antibiotics, pesticides and nitroaromatic compounds
Lee et al. Torsionally Responsive C 3-Symmetric Azo Dyes: Azo− Hydrazone Tautomerism, Conformational Switching, and Application for Chemical Sensing
CN102911111B (en) Carbazole benzaldehyde-p-phenylenediamine bi-schiff base and preparation method thereof
CN104130192A (en) Imidazolyl-benzaldehyde p-phenylenediamine bis-Schiff base and preparation method thereof
Boedigheimer et al. Porphyrin on a half-shell! Synthesis and characterization of corannulenoporphyrins
Zhang et al. Four coordination polymers constructed by a novel octacarboxylate functionalized calix [4] arene ligand: syntheses, structures, and photoluminescence property
CN104004514A (en) Symmetrical double-rhodamine fluorescent probe for detecting trivalent bismuth ions as well as preparation method and use thereof
CN109761992A (en) A kind of triazole benzaldehyde contracting rhodamine hydrazine hydrate schiff bases and preparation method thereof
CN105541876A (en) Anthraquinone-bridged N-heterocyclic carbene metal complex and preparation method and application thereof
CN103804386B (en) 4,5-dihydroxyl-3-H-spiral shell [furans-2,3 '-indoles]-2 '-one derivative and synthetic method thereof and application
Padhy et al. Imidazole derivatives as the organic precursor of ZnO nano particle
CN112062756A (en) Mannhouse donor-acceptor adduct of furan and 3-pyridine ethylamine activated by Merlox acid and synthetic method thereof
CN109762034B (en) Preparation method of novel terephthalaldehyde D-glucosamine Schiff base
Bulut et al. Catalyst-Free Synthesis of Aryl Diamines via a Three-Step Reaction Process
Grover et al. Facile conversion of Ni (II) cyclopropylchlorins into novel β-substituted porphyrins through acid-catalyzed ring-opening reaction
CN107253921A (en) A kind of acylhydrazone containing pyrenyl and its preparation method and application
Chahal et al. Facile synthesis of functionalized urea, imidazolium salt, azide, and triazole from a 2-amino-5, 7-dimethyl-1, 8-naphthyridine scaffold and their utilization in fluoride ion sensing
González-Lorenzo et al. A Schiff-base bibracchial lariat ether forming a cryptand-like cavity for lanthanide ions
Mei et al. Synthesis of substituted 2-alkylquinolines by visible-light photoredox catalysis
CN107043353A (en) A kind of imidazoles benzaldehyde-p-phenylenediamine bi-schiff base and preparation method thereof
CN104119286B (en) A kind of triazole benzaldehyde-p-phenylenediamine bi-schiff base and preparation method thereof
Teramae et al. Dinuclear copper–dioxygen intermediates supported by polyamine ligands
Jin et al. An Efficient Synthesis of Chromeno [4, 3‐d] isoxazolo [5, 4‐b] pyridin‐6‐one Derivatives
Shardin et al. Synthesis and structural characterization of N-bromobenzoyl-N󸀠-(1, 10-phenanthrolin-5-yl) thiourea derivatives
Dutta et al. BF2‐Complexes of Carbazole–Benzimidazole Conjugates: Synthesis, Structures, and Spectroscopic Properties

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20170524

Termination date: 20170730

CF01 Termination of patent right due to non-payment of annual fee